Be The First To
Progenics Pharmaceuticals is taking a proactive approach to fighting serious diseases. The company develops biotech drugs with oncology and virology applications, as well as therapeutics used in clinical care settings. Progenics' commercial product Relistor, which blocks the side effects of opioids without lessening their pain-killing power, is approved as an injectable treatment for opioid-induced constipation (OIC) in terminally ill patients. The drug was developed in collaboration with Wyeth Pharmaceuticals (now part of Pfizer). Also in the firm's pipeline are a...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees are “Dissatisfied” 6 ratings
0% of the CEO 2 ratings
Mark R. Baker
CEO, General Counsel, Secretary, and Director
|Salaries in USD||Avg. Salary|| |
6 Progenics Pharmaceuticals Salaries
4 Progenics Pharmaceuticals Salaries
1 Progenics Pharmaceuticals Salary
= Salary Range
= Anonymous Salary Range
Declined Offer – Interviewed in Jan 2009 – Reviewed Mar 29, 2011
Interview Details – last about 2 hours. went through resume with each interviewer and they asked a few technical questions based on your resume. one of the interviewer arrived late. just chat with the hiring manager while waiting. – Full Interview
Let us know if we're missing any workplace or industry recognition –